These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35222283)

  • 1. Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma.
    Wang WM; Yang SS; Shao SH; Nie HQ; Zhang J; Su T
    Front Endocrinol (Lausanne); 2022; 13():828608. PubMed ID: 35222283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin reduces the increased risk of oral squamous cell carcinoma recurrence in patients with type 2 diabetes mellitus: A cohort study with propensity score analyses.
    Hu X; Xiong H; Chen W; Huang L; Mao T; Yang L; Wang C; Huang D; Wang Z; Yu J; Shu Y; Xia K; Su T
    Surg Oncol; 2020 Dec; 35():453-459. PubMed ID: 33065527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of up-regulation of Decorin on expression of EGFR, C-Myc and p21 in nude mice with oral squamous cell carcinoma].
    Guo MY; Li KY; Nie MH; Liu XQ
    Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):40-46. PubMed ID: 36973842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma.
    Tseng YK; Chen CF; Shu CW; Lee CH; Chou YT; Li YJ; Liou HH; Cheng JT; Chen CL; Ger LP; Liu PF
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
    Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
    Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
    Liu J; Zhao J; Qiao X
    Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
    Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
    Mehta A; Chowdhary M; Sinha R
    J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Calderwood SK; Okamoto K; Kozaki KI
    Oral Oncol; 2018 Nov; 86():251-257. PubMed ID: 30409309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
    BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
    Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
    J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties
    Hotta H; Hamamura K; Shibuya H; Ohmi Y; Furukawa K; Furukawa K
    Anticancer Res; 2021 Apr; 41(4):1821-1830. PubMed ID: 33813387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
    Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
    Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
    Zheng S; Wu R; Deng Y; Zhang Q
    Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy.
    Minabe M; Akiyama Y; Higa K; Tachikawa T; Takahashi S; Nomura T; Kouno M
    Exp Dermatol; 2019 May; 28(5):614-617. PubMed ID: 30907457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.